Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2016

Mili(Norgestimate-Ethinyl Estradiol)Aurobindo Pharma Limited logoAUROPHARMA.NS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Aurobindo Pharma Limited

$144K

Medicare cost, 2024

Medicare drug plans spent $143,629 on Mili (norgestimate-ethinyl estradiol) in 2024, for 6,349 prescriptions and refills filled by 1,997 patients. Spending fell 23% from 2023 to 2024. Indiana accounts for the most spending ($12,165, 8% of the total). It is made by Aurobindo Pharma Limited (AUROPHARMA.NS).

Medicare cost, 2024

$144K

-23.1% from 2023

Prescriptions

6,349

$22.62 per claim

Patients

1,997

2,237 prescribers

Total spending, 2024

$144K

$71.92 per patient

Questions and answers

How much does Medicare spend on Mili?

Medicare prescription drug plans paid $144K for Mili in 2024, for 6,349 prescriptions and refills to 1,997 patients (down 23.1% from 2023). The average cost per claim was $22.62.

Which state spends the most on Mili?

Indiana had the highest Medicare cost for Mili in 2024: $12K for 599 claims, followed by Florida ($11K).

Who prescribes Mili the most?

Angela H Grimaldo, nurse practitioner in Dallas, TX, had the highest Medicare cost for Mili in 2024: 25 claims costing $717.

Who makes Mili?

Mili is made by Aurobindo Pharma Limited (AUROPHARMA.NS), listed in the Medicare spending data as Aurobindo Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Mili was $144K in 2024, after a high of $211K in 2021.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Mili, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Angela H Grimaldo Dallas, TXNurse Practitioner25Under 11$717
1508856170 Internal Medicine20Under 11$532
Sana Hira Chicago, ILPhysician Assistant17Under 11$465
Kavitha Srinivasan Glenview, ILInternal Medicine15Under 11$424
Mary Wildeman Nashville, TNNurse Practitioner13Under 11$352
Asma M Syeda West Mifflin, PAFamily Practice12Under 11$334
Elisabeth Cooper Redding, CAPhysician Assistant12Under 11$320
James E Thompson Bedford, VAFamily Practice11Under 11$311
Jessica Roberts Antioch, CAFamily Practice13Under 11$302
Kimberly D Massey Tifton, GANurse Practitioner13Under 11$296
Jacob F Cogen Pleasantville, NJFamily Practice11Under 11$279
Christopher R Wainwright Jacksonville, FLFamily Practice13Under 11$259
Kimberly A Hindi Montgomery, ALNurse Practitioner13Under 11$259
Carol A Ketchen Spartanburg, SCObstetrics & Gynecology13Under 11$259
Julie A Raekes Richland, WAInternal Medicine11Under 11$256
Sailaja M Blackmon Fort Wayne, INObstetrics & Gynecology13Under 11$255
Kristen Green Lincoln, ILObstetrics & Gynecology13Under 11$255
Wayne Blevins Jr. Carlinville, ILEmergency Medicine13Under 11$255
Heather Doolittle Auburn, INNurse Practitioner12Under 11$252
Herndon M Jeansonne II Cottonport, LANurse Practitioner13Under 11$246
Steven H Lee Austell, GAObstetrics & Gynecology13Under 11$237
Aimee Diaz Tamarac, FLNurse Practitioner13Under 11$233
James P McDermott Manahawkin, NJObstetrics & Gynecology16Under 11$227
Jessica E Horvath - Matthews Sewell, NJFamily Practice13Under 11$206
Stacey L Walter Mc Arthur, OHFamily Practice11Under 11$201

Prescriber data by year

YearPrescribersClaimsPatientsCost
20222,2656,1512,047$199K
20232,2706,4262,040$187K
20242,2376,3491,997$144K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Aurobindo PharmAUROPHARMA.NS logoAUROPHARMA.NS6,349$144K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
6
RxNorm concept IDs
1800499, 240128, 748797, 749860
Application numbers
ANDA205449

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube